Sources of Funding: This study is self-funded.
Treatment of demodicosis in dogs: 2011 clinical practice guidelines
Article first published online: 13 FEB 2012
© 2012 The Authors. Veterinary Dermatology. © 2012 ESVD and ACVD
Volume 23, Issue 2, pages 86–e21, April 2012
How to Cite
Mueller, R. S., Bensignor, E., Ferrer, L., Holm, B., Lemarie, S., Paradis, M. and Shipstone, M. A. (2012), Treatment of demodicosis in dogs: 2011 clinical practice guidelines. Veterinary Dermatology, 23: 86–e21. doi: 10.1111/j.1365-3164.2011.01026.x
Conflict of Interest: In the last 5 years, Ralf Mueller has obtained funding, lectured or consulted for Bayer Animal Health, Boehringer Ingelheim, Dechra Veterinary Products, Intervet, Merial, Novartis Animal Health, Pfizer Animal Health, Procter & Gamble, Royal Canin, Selectavet and Virbac. Emmanuel Bensignor has obtained funding for studies, lectured or consulted for the following companies selling products for demodicosis: Bayer Animal Health, Novartis Animal Health and Pfizer Animal Health. Lluís Ferrer has obtained funding, lectured or consulted for Novartis, Bayer Animal Health, Virbac, Merial, Intervet, Esteve Veterinaria and Elanco. Birgit Holm has obtained funding for studies, lectured or consulted for Bayer Animal Health and Novartis Animal Health. Manon Paradis has participated in a study funded by Bayer Animal Health. Michael Shipstone has received funding for studies and lectures from Pfizer Animal Health, Schering Plough and Virbac Australia.
- Issue published online: 12 MAR 2012
- Article first published online: 13 FEB 2012
- Accepted 24 October 2011
- 11Hat Jeder Hautgesunde Hund Demodexmilben? Histologische Untersuchungen von Hautproben. Berlin: Freie Universität, 1988; 141..
- 16An unusual presentation of generalised demodicosis caused by a long-bodied demodex mite in a Lakeland Terrier. Australian Veterinary Practitioner 1999; 29: 128–131., .
- 18Eight cases of demodicosis caused by a long-bodied Demodex species (1997–2002). Australian Veterinary Practice 2003; 33: 64–72., , et al.
- 21Variation in size in Demodex canis: from the longest to the shortest forms. Veterinary Dermatology 2010; 21: 213 (Abstract)..
- 27Canine demodicosis. Muller & Kirk’s Small Animal Dermatology. Philadelphia, W.B. Saunders, 2001: 457–474., , .
- 28Spontaneous remission in canine generalized demodicosis – predisposing factors. Veterinary Dermatology 2011; 22: 301 (Abstract)., .
- 31Skin scrapings and skin biopsies. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. Philadelphia, W.B. Saunders, 2010; 368–371., .
- 32Comparison of skin scrapes and hair plucks for detecting Demodex mites in canine demodicosis, a multicentre, prospective study. Veterinary Dermatology, 2007; 18: 381 (Abstract)., , et al.
- 33Comparaison de trois techniques diagnostiques de demodecie a Demodex canis chez le chien. Pratique Medicale and Chirurgicale de l’Animal de Compagnie 2003; 38: 167–171..
- 36Topical dermatological therapy. In: Maddison JE, Page SW, Church DB, eds. Small Animal Pharmacology. Philadelphia, W.B. Saunders, 2008; 546–556..
- 38The efficacy of amitraz for generalized demodicosis in dogs: a study of two concentrations and frequencies of application. The Compendium on Continuing Education for the Practising Veterinarian 1985; 7: 8–17., , .
- 40Amitraz treatment of demodicosis. Journal of the American Animal Hospital Association 1983; 19: 435–441..
- 41Milbemycin oxime in the treatment of canine demodicosis. Australian Veterinary Practitioner 1995; 25: 122–126., .
- 43Efficacy of metaflumizone plus amitraz for the treatment of juvenile and adult onset demodicosis in dogs: pilot study of 24 dogs. Veterinary Dermatology 2009; 20: 227 (Abstract)..
- 48Experiences with the use of amitraz and ivermectin for the treatment of generalized demodicosis in dogs. Journal of the American Animal Hospital Association 1985; 21: 535–541., .
- 50Traitement de la demodecie generalisee du chien par l’ivermectine: a propos de 20 cas. Pratique Medicale et Chirurgicale de l’Animal de Compagnie 1996; 31: 31–40..
- 52Daily oral ivermectin for the treatment of generalised demodicosis in 23 dogs. Australian Veterinary Practitioner 1999; 29: 132–136., , .
- 60The ABCB1-1Δ mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis. Veterinary Dermatology 2009; 20: 60–66., , et al.
- 61Moxidectin in the treatment of generalized demodicosis in dogs. A pilot study: 8 cases. In: Kwochka KW, Willemse T, Von Tscharner C, eds. Advances in Veterinary Dermatology. Oxford, Butterworth-Heinemann, 1998; 554–555., .
- 62Evaluation of the clinical efficacy of two different doses of moxidectin in the treatment of generalized demodicosis in the dog. Annual Meeting of the Australian College of Veterinary Scientists, Goold Coast, Australia, 1997..
- 64Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Parasitological Research 2005; 97(Suppl 1): S89–S96., , et al.
- 66Doramectin as a treatment for canine and feline demodicosis. Australian Veterinary Practitioner 2002; 32: 98–103..
- 72Detection of the nt230(del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed predisposition, and microsatellite analysis. Journal of Veterinary Pharmacology and Therapeutics 2007; 30: 482–485., , et al.
- 74Zur Demodikose des Hundes. Kleintierpraxis 1997; 42: 745–754., , .
- 76Anon. Dermatologists recommend neutering of canine patients with demodicosis. Journal of the American Veterinary Medical Association 1983; 182: 1048.